The most common indicators of Alpha-1 include shortness of breath, a chronic cough, and abnormal liver test results. If you have any of these symptoms there is a simple blood test that can detect alpha-1 antitrypsin levels. This test is also recommended if you have relatives, especially siblings, who have been diagnosed with alpha-1, or if there is a family history of early emphysema, with or without smoking.
The laboratory test measures alpha-1 antitrypsin levels in the blood, which are reported using two units of measurement: milligrams per 100 ml (mg%) and micromoles per liter (µM/L). Both measurements provide the same basic information on how much alpha-1 antitrypsin is in the blood.
People with two healthy copies of the alpha-1 gene produce the most alpha-1 antitrypsin, and people with no copies of the gene at all produce the least. In addition, environmental factors can affect how much alpha-1 antitrypsin is in the blood. An individual's genetic makeup (genotype) combines with environmental factors to determine their phenotype. Here are the more common phenotypes and their corresponding blood alpha-1 levels.
Phenotype |
µM/L |
mg% |
MM (two normal copies) |
20-53 |
150-350 |
MZ (one normal copy, one deficient copy) |
12-28 |
90-210 |
SS (two marginally deficient copies) |
13-27 |
100-210 |
SZ (one deficient copy, one marginally deficient copy) |
10-16 |
75-120 |
ZZ (two deficient copies) |
2.5-7 |
20-45 |
NULL (two nonfunctional copies) |
0 |
0 |
Alpha-1 levels of 11 µM/L (80 mg%) or less put you at greatest risk of developing alpha-1 related emphysema. Smokers with intermediate deficiency levels (80 - 160 mg%) are also at increased risk of lung disease.
In the table above, M refers to the normal gene. Over 75 combinations of gene variations (alleles) have been identified, some of which can cause Alpha-1. The S, Z and Null genes are the most common ones that cause alpha-1 deficiencies. ZZ is the most common allele that causes lung disease.
The Null gene is one that produces no detectable levels of alpha-1. Alphas with the Null-Null phenotype are at the greatest risk of developing emphysema, yet none have suffered liver damage as a result of their Alpha-1
For more information on Alpha-1 testing, please click here to visit the Alpha-1 Foundation's webpage.




